SCHEMBL21780574

SCHEMBL21780574

CC(CCNC(=O)OC(C)(C)C)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 1/20 0.52
▸ IDO1 P14902 1/20 0.51
▸ MAPT P10636 1/20 0.48
▸ KCNA5 P22460 1/20 0.48
▸ MEN1 O00255 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ CTSS P25774 4/20 0.46
▸ PPARA Q07869 1/20 0.46
▸ CTSK P43235 4/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ MALT1 Q9UDY8 1/20 0.45
▸ CTSL P07711 1/20 0.44
▸ CTSB P07858 1/20 0.44
▸ SIGMAR1 Q99720 1/20 0.44
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA7 P43166 1/20 0.44
▸ CA14 Q9ULX7 1/20 0.44
▸ NTSR1 P30989 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13334305 0.90 MAPT (0.55) SYKIDO1MAPTMEN1GAA
SCHEMBL22278395 0.87 MAPT (0.50) SYKIDO1MAPTMEN1GAA
SCHEMBL19608402 0.86 SYK (0.60) SYKIDO1MAPTMEN1KMT2A
SCHEMBL17786967 0.86 SYK (0.51) SYKIDO1MAPTMEN1GAA
SCHEMBL17786969 0.86 SYK (0.51) SYKIDO1MAPTMEN1GAA
SCHEMBL1569320 0.85 SYK (0.50) SYKIDO1MAPTMEN1GAA
SCHEMBL12472349 0.84 SYK (0.49) SYKIDO1MAPTMEN1GAA
SCHEMBL30572143 0.84 SYK (0.52) SYKIDO1MAPTMEN1GAA
SCHEMBL1568594 0.83 IDO1 (0.50) SYKIDO1MAPTMEN1GAA
SCHEMBL5440929 0.81 SYK (0.64) SYKIDO1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047239-A1 INHIBITING αV β6 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2020-03-05 — — WO disclosed
EP-3617206-A1 INTEGRIN INHIBITORS Morphic Therapeutic, Inc. (US) 2020-03-04 — — EP disclosed
Send feedback